drugset / Trial / NCT01929421

A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer.

NCT01929421 ↗

Phase 2 Completed 36 enrolled Gachon University Gil Medical Center
NaSingle-groupOpen-labelTreatment

Summary

To assess the efficacy and safety of salvage tratment with Gemcitabine and S-1 Combination in metastatic colorectal cancer

Timeline

Start
2009-12
Primary completion
2013-06
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — —
Subject S-1 Small molecule — —

Indications